Hiv Drugs Market Size, Production, Growth Segments, Business Growth Opportunities to 2034 - openP...

Hiv Drugs Market Size, Production, Growth Segments, Business Growth Opportunities to 2034  openPR.com

Merck's HIV treatment meets main goal in two late-stage studies - Reuters

Merck's HIV treatment meets main goal in two late-stage studies  Reuters

A Potential Cure for AIDS: Defeating HIV With a Single Injection - SciTechDaily

A Potential Cure for AIDS: Defeating HIV With a Single Injection  SciTechDaily

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls - World Health...

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls  World Health Organization (WHO)

Can babies infected with HIV be cured? New study offers cautious optimism - Science | AAAS

Can babies infected with HIV be cured? New study offers cautious optimism  Science | AAAS

Some children who start antiretrovirals very early may control HIV after stopping treatment - Aid...

Some children who start antiretrovirals very early may control HIV after stopping treatment  Aidsmap

HIV positive sperm bank launched in New Zealand - News-Medical

HIV positive sperm bank launched in New Zealand  News-Medical

Monthly HIV injection could free patients from gruelling drug regimen - Nature

Monthly HIV injection could free patients from gruelling drug regimen  Nature

Merck's HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies - Fier...

Merck's HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies  Fierce Biotech

HIV services in Ukraine resilient but starting to feel the strain - Aidsmap

HIV services in Ukraine resilient but starting to feel the strain  Aidsmap

Will post-treatment controllers guide us towards an HIV cure? - Aidsmap

Will post-treatment controllers guide us towards an HIV cure?  Aidsmap

Ultra-long-acting cabotegravir could be taken three times a year for HIV PrEP and treatment - Aid...

Ultra-long-acting cabotegravir could be taken three times a year for HIV PrEP and treatment  Aidsmap

So far, Poland has seen fewer Ukrainian refugees with HIV than expected - Aidsmap

So far, Poland has seen fewer Ukrainian refugees with HIV than expected  Aidsmap

After viral rebound, dolutegravir-based treatment more likely to suppress HIV - Aidsmap

After viral rebound, dolutegravir-based treatment more likely to suppress HIV  Aidsmap

Further evidence that recycling tenofovir in second-line treatment is effective - Aidsmap

Further evidence that recycling tenofovir in second-line treatment is effective  Aidsmap

London patient in long-term HIV remission after stem cell transplant - Aidsmap

London patient in long-term HIV remission after stem cell transplant  Aidsmap

European AIDS Treatment Group documents the impact of COVID on HIV services throughout Europe - A...

European AIDS Treatment Group documents the impact of COVID on HIV services throughout Europe  Aidsmap

People-centred blood pressure management improves blood pressure in people with HIV - Aidsmap

People-centred blood pressure management improves blood pressure in people with HIV  Aidsmap

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds...

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds  Aidsmap

What are the roles of TAF and integrase inhibitors in weight gain? - Aidsmap

What are the roles of TAF and integrase inhibitors in weight gain?  Aidsmap

Two-thirds of people living with HIV would like to try injectable treatment, according to Europea...

Two-thirds of people living with HIV would like to try injectable treatment, according to European survey  Aidsmap

Earlier treatment and higher CD4 counts linked to smaller HIV reservoir - Aidsmap

Earlier treatment and higher CD4 counts linked to smaller HIV reservoir  Aidsmap

Second-line treatment nearly nine times more expensive than first-line in upper-middle income cou...

Second-line treatment nearly nine times more expensive than first-line in upper-middle income countries  Aidsmap

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing ...

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing therapy  Aidsmap

Islatravir plus doravirine remains effective at 96 weeks - Aidsmap

Islatravir plus doravirine remains effective at 96 weeks  Aidsmap

Dolutegravir recommended for all in new World Health Organization guidelines - Aidsmap

Dolutegravir recommended for all in new World Health Organization guidelines  Aidsmap

South Africa: dropping out of HIV care is deadly - Aidsmap

South Africa: dropping out of HIV care is deadly  Aidsmap

SEARCH study finds universal 'test and treat' reduces infant HIV - Aidsmap

SEARCH study finds universal 'test and treat' reduces infant HIV  Aidsmap

Reappearance of HIV in "Mississippi Baby" poses questions for early treatment - Aidsmap

Reappearance of HIV in "Mississippi Baby" poses questions for early treatment  Aidsmap

Infected blood: Devon mum not told for three years of son's HIV - BBC

Infected blood: Devon mum not told for three years of son's HIV  BBC

Oral six-month treatment for MDR-TB is safe and effective in people with HIV - Aidsmap

Oral six-month treatment for MDR-TB is safe and effective in people with HIV  Aidsmap

South Africa saves $326 million on dolutegravir - Aidsmap

South Africa saves $326 million on dolutegravir  Aidsmap

Progress on 90-90-90 HIV targets shows stark gap between eastern and western Europe - Aidsmap

Progress on 90-90-90 HIV targets shows stark gap between eastern and western Europe  Aidsmap

How an Indian tycoon fought Big Pharma to sell AIDS drugs for $1 a day - qz.com

How an Indian tycoon fought Big Pharma to sell AIDS drugs for $1 a day  qz.com

Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries - Aid...

Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries  Aidsmap

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women - Aid...

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women  Aidsmap

Genetically engineered white blood cells could be the future of HIV treatment - The Verge

Genetically engineered white blood cells could be the future of HIV treatment  The Verge

ADVANCE trial shows dolutegravir is highly effective in South Africa - Aidsmap

ADVANCE trial shows dolutegravir is highly effective in South Africa  Aidsmap

Are CD4 counts still useful in the 'treat all' era? - Aidsmap

Are CD4 counts still useful in the 'treat all' era?  Aidsmap

Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir...

Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label,  The Lancet

In Coronavirus, China Weighs Benefits of Buffalo Horn and Other Remedies (Published 2020) - The N...

In Coronavirus, China Weighs Benefits of Buffalo Horn and Other Remedies (Published 2020)  The New York Times

Myanmar on brink of HIV treatment crisis - Frontier Myanmar

Myanmar on brink of HIV treatment crisis  Frontier Myanmar

(PDF) Understanding the role of social workers in the promotion and uptake of prevention of mothe...

(PDF) Understanding the role of social workers in the promotion and uptake of prevention of mother-to-child transmission of HIV in Zimbabwe  ResearchGate

Tele-harm reduction: a new approach in the US shows promise for people with HIV who inject drugs ...

Tele-harm reduction: a new approach in the US shows promise for people with HIV who inject drugs (Mandarin)  Aidsmap

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin) ...

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin)  Aidsmap

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV (Mandarin) - Aidsmap

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV (Mandarin)  Aidsmap